FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Egbert Smit

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Robert A A van Boerdonk; Bauke Ylstra; Elisabeth Bloemena; Ruud H Brakenhoff; Johannes M A Daniels; Katrien Grunberg; Oscar Krijgsman; Chris J L M Meijer; Egbert F Smit; Peter J F Snijders; Renske D M Steenbergen; Daniëlle A M Heideman
High-risk human papillomavirus-positive lung cancer: molecular evidence for a pattern of pulmonary metastasis.
J L G Blaauwgeers; Jacobus A Burgers; Max Dahele; Lea M Dijksman; Koen J Hartemink; Ingrid Kappers; Houke Klomp; Jan W Oosterhuis; Marinus A Paul; Erik C Phernambucq; Pieter E Postmus; Egbert F Smit; Cornelis G Vos; Birgit I Witte; José S A Belderbos; Erik Thunnissen
Complete pathological response is predictive for clinical outcome after tri-modality therapy for carcinomas of the superior pulmonary sulcus.
Astrid A M van der Veldt; Egbert F Smit; Adriaan A Lammertsma
Cancer therapy: could a novel test predict the amount of drug that reaches its target?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Egbert Smit (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Robert A A van Boerdonk; Bauke Ylstra; Elisabeth Bloemena; Ruud H Brakenhoff; Johannes M A Daniels; Katrien Grunberg; Oscar Krijgsman; Chris J L M Meijer; Egbert F Smit; Peter J F Snijders; Renske D M Steenbergen; Daniëlle A M Heideman
High-risk human papillomavirus-positive lung cancer: molecular evidence for a pattern of pulmonary metastasis.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2013;8(6):711-8.
2013: J L G Blaauwgeers; Jacobus A Burgers; Max Dahele; Lea M Dijksman; Koen J Hartemink; Ingrid Kappers; Houke Klomp; Jan W Oosterhuis; Marinus A Paul; Erik C Phernambucq; Pieter E Postmus; Egbert F Smit; Cornelis G Vos; Birgit I Witte; José S A Belderbos; Erik Thunnissen
Complete pathological response is predictive for clinical outcome after tri-modality therapy for carcinomas of the superior pulmonary sulcus.
Virchows Archiv : an international journal of pathology 2013;462(5):547-56.
2013: Astrid A M van der Veldt; Egbert F Smit; Adriaan A Lammertsma
Cancer therapy: could a novel test predict the amount of drug that reaches its target?
Expert review of anticancer therapy 2013;13(4):377-9.
2013: J L Kuiper; Egbert F Smit
High-dose, pulsatile erlotinib in two NSCLC patients with leptomeningeal metastases--one with a remarkable thoracic response as well.
Lung cancer (Amsterdam, Netherlands) 2013;80(1):102-5.
2013: Terry G Wiersma; Max Dahele; Patricia F de Haan; Ben J Slotman; Egbert F Smit; Peter M van de Ven; Ellen J F van Reij; Wilko F A R Verbakel; Suresh Senan
Concurrent chemoradiotherapy for large-volume locally-advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2013;80(1):62-7.
2013: Ellen Siebring-van Olst; Egbert F Smit; Renee X de Menezes; Michael Howell; Christie Vermeulen; Victor W van Beusechem
Affordable luciferase reporter assay for cell-based high-throughput screening.
Journal of biomolecular screening 2013;18(4):453-61.
2013: Anne-Marie C Dingemans; Harry J M Groen; Daniëlle A M Heideman; Peter W A Kunst; Wouter W Mellema; Erik Thunnissen; Atie van Wijk; Sjaak A Burgers; Egbert F Smit
A phase II study of sorafenib in patients with platinum-pretreated, advanced (Stage IIIb or IV) non-small cell lung cancer with a KRAS mutation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013;19(3):743-51.
2013: Idris Bahce; Daniëlle A M Heideman; Adriaan A Lammertsma; Mark Lubberink; Pieter E Postmus; Robert Schuit; Egbert F Smit; Erik Thunnissen; Astrid A M van der Veldt; Albert D Windhorst; Maqsood Yaqub; N Harry Hendrikse
Development of [(11)C]erlotinib positron emission tomography for in vivo evaluation of EGF receptor mutational status.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013;19(1):183-93.
2013: Elisa Giovannetti; Richard Honeywell; Mariette Labots; J S W Lind; H Dekker; E Galvani; R Sciarrillo; Egbert F Smit; Hendrik Verheul; Godefridus J Peters
Molecular mechanisms and modulation of key pathways underlying the synergistic interaction of sorafenib with erlotinib in non-small-cell-lung cancer (NSCLC) cells.
Current pharmaceutical design 2013;19(5):927-39.
2012: Andrea Ardizzoni; Fausto Barbieri; Corrado Boni; Luca Boni; Sebastiano Buti; Mara A Cafferata; Andrea Camerini; Roberta Camisa; Libero Ciuffreda; Ida Colantonio; Lucio Crinò; Filippo de Marinis; Francesco Di Costanzo; Giovenzio Genestreti; Roberto Labianca; Rodolfo Mattioli; Rodolfo Passalacqua; Antonio Pazzola; Antonio Santo; Carmelo Tibaldi; Marcello Tiseo; Andrew D Vincent; Nicoletta Zilembo; Domenico Amoroso; Egbert F Smit
Pemetrexed versus pemetrexed and carboplatin as second-line chemotherapy in advanced non-small-cell lung cancer: results of the GOIRC 02-2006 randomized phase II study and pooled analysis with the NVALT7 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(36):4501-7.
2012: Erik Thunnissen; Matthijs van Oosterhout; Robertjan van Suylen; Jan von der Thusen; Bart Vrugt; Anne Wiersma; Birgit I Witte; Evan Boers; Katrien Grunberg; Daniëlle A M Heideman; Dirk J Kuik; Arnold Noorduin; Divera Pronk; Cees Seldenrijk; Hannie Sietsma; Egbert F Smit; Michael A Den Bakker
Correlation of immunohistochemical staining p63 and TTF-1 with EGFR and K-ras mutational spectrum and diagnostic reproducibility in non small cell lung carcinoma.
Virchows Archiv : an international journal of pathology 2012;461(6):629-38.
2012: Martin Reck; Egbert F Smit; Ewa Szutowicz-Zielinska; Nick Thatcher; Katherine B Winfree; Susan C Guba; Astra M Liepa; Paul Lorigan; Patrick Peterson; Mark A Socinski
Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin.
Lung cancer (Amsterdam, Netherlands) 2012;78(3):276-81.
2012: Astrid A M van der Veldt; Adriaan A Lammertsma; Egbert F Smit
Scheduling of anticancer drugs: timing may be everything.
Cell cycle (Georgetown, Tex.) 2012;11(23):4339-43.
2012: J L Kuiper; J S W Lind; H Roder; J Roder; A M C Dingemans; J Grigorieva; H J M Groen; Egbert F Smit
VeriStrat(®) has prognostic value in advanced stage NSCLC patients treated with erlotinib and sorafenib.
British journal of cancer 2012;107(11):1820-5.
2012: Julien Vincenten; Wim Vos; Birgit I Witte; Katrien Grunberg; Daniëlle A M Heideman; Joop Kuik; Gerrit Meijer; Pieter E Postmus; Egbert F Smit; Peter J F Snijders; Erik Thunnissen
Negative NKX2-1 (TTF-1) as temporary surrogate marker for treatment selection during EGFR-mutation analysis in patients with non-small-cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(10):1522-7.
2012: Marcello Tiseo; Andrew Vincent; Fausto Barbieri; Jacobus A Burgers; Andrea Camerini; Francesco Di Costanzo; Elisa Giovannetti; Godefridus J Peters; Egbert F Smit; Carmelo Tibaldi; Andrea Ardizzoni
Pharmacogenetic study of patients with advanced non-small cell lung cancer (NSCLC) treated with second-line pemetrexed or pemetrexed-carboplatin.
Lung cancer (Amsterdam, Netherlands) 2012;78(1):92-9.
2012: Martijn R Groenendijk; Marinus A Paul; Paul P Eijk; Egbert F Smit; Erik Thunnissen; Mark A van de Wiel; Bauke Ylstra; Pieter E Postmus
An 82-year-old woman with small-cell lung cancer: relapse after 9 years or a new primary?
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(8):e3-5.
2012: Alain Vergnenegre; Carla Visseren-Grul; Giovanni Zanotti; Kees Kraaij; Barbara Parente; Stephan Schmitz; Egbert F Smit; Victoria Soldatenkova; Kaisa Taipale; elizabeth toy; denis moro-sibilot
Second-line therapy for non-small cell lung cancer in clinical practice: final results and treatment pathways from the SELECTTION observational study.
Current medical research and opinion 2012;28(8):1253-62.
2012: Erik C J Phernambucq; Pieter E Postmus; Emile F I Comans; Koen J Hartemink; Marinus A Paul; Egbert F Smit; Suresh Senan
Tumor cavitation in patients with stage III non-small-cell lung cancer undergoing concurrent chemoradiotherapy: incidence and outcomes.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(8):1271-5.
2012: Egbert F Smit; M A Socinski; Aleksandra Szczesna; Joachim von Pawel; tudor ciuleanu; S C Guba; S Hong; R R Hozak; N A Karaseva; P Lorigan; B P Mullaney; S P Myrand; D Ohannesian; E Powell; Martin Reck; Giorgio V Scagliotti; N Thatcher
Biomarker analysis in a phase III study of pemetrexed-carboplatin versus etoposide-carboplatin in chemonaive patients with extensive-stage small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(7):1723-9.
2012: A Jasmijn Hubers; Peter W Kunst; Pieter E Postmus; Egbert F Smit; Henk J Smit; Peter J F Snijders; Peter J Sterk; Sjaak A Burgers; Sylvia Duin; Daniëlle A M Heideman; Gerarda J M Herder; Birgit I Witte; Erik Thunnissen
Prolonged sampling of spontaneous sputum improves sensitivity of hypermethylation analysis for lung cancer.
Journal of clinical pathology 2012;65(6):541-5.
2012: Joop de Langen; Ronald Boellaard; Maarten Boers; Lalitha K Shankar; Egbert F Smit; Sigrid Stroobants; Harm van Tinteren; Linda M Velasquez; Andrew Vincent; Wolfgang A Weber; Otto S Hoekstra
Repeatability of 18F-FDG uptake measurements in tumors: a metaanalysis.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2012;53(5):701-8.
2012: Daniëlle A M Heideman; Irene Lurkin; Gerrit A Meijer; Egbert F Smit; Peter J F Snijders; Erik Thunnissen; Hendrik Verheul; Marije Doeleman; Ellen C Zwarthoff
KRAS and BRAF mutation analysis in routine molecular diagnostics: comparison of three testing methods on formalin-fixed, paraffin-embedded tumor-derived DNA.
The Journal of molecular diagnostics : JMD 2012;14(3):247-55.
2012: Frank J Lagerwaard; Marinus A Paul; Ben Slotman; Egbert F Smit; Naomi E Verstegen; Cornelis J A Haasbeek; Suresh Senan
Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.
International journal of radiation oncology, biology, physics 2012;83(1):348-53.
2012: Markus Joerger; Egbert F Smit; Paul H M Smits; Andrew Vincent; Paul Baas; Martin P L Bard; Jos H Beijnen; Sjaak A Burgers; Valerie D Doodeman; Tjeerd J Haitjema; Alwin D R Huitema; Jan H M Schellens
Germline polymorphisms in patients with advanced nonsmall cell lung cancer receiving first-line platinum-gemcitabine chemotherapy: a prospective clinical study.
Cancer 2012;118(9):2466-75.
2012: Astrid A M van der Veldt; Egbert F Smit
Bevacizumab in neoadjuvant treatment for breast cancer.
The New England journal of medicine 2012;366(17):1637; author reply 1638-40.
2012: C van der Leest; N van Walree; R J Versteijlen; J Baas; Henk C Hoogsteden; Egbert F Smit; Joachim G J V Aerts
SUVmax during 18FDG-PET scanning in small cell lung cancer: similar information as in non-small cell lung cancer?
Lung cancer (Amsterdam, Netherlands) 2012;76(1):67-71.
2012: Joline S W Lind; Suresh Senan; Egbert F Smit
Pulmonary toxicity after bevacizumab and concurrent thoracic radiotherapy observed in a phase I study for inoperable stage III non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(8):e104-8.
2012: B S van der Meij; J A E Langius; M A Paul; S M Slootmaker; Egbert F Smit; Marieke D Spreeuwenberg; P A M van Leeuwen
Oral nutritional supplements containing n-3 polyunsaturated fatty acids affect quality of life and functional status in lung cancer patients during multimodality treatment: an RCT.
European journal of clinical nutrition 2012;66(3):399-404.
2012: Astrid A M van der Veldt; Hendrik Verheul; Maudy Walraven; Albert D Windhorst; Idris Bahce; Michiel P de Boer; Jonas Eriksson; Henri N J M Greuter; N Harry Hendrikse; Adriaan A Lammertsma; Mark Lubberink; Pieter E Postmus; Erik H Serné; Egbert F Smit
Rapid decrease in delivery of chemotherapy to tumors after anti-VEGF therapy: implications for scheduling of anti-angiogenic drugs.
Cancer cell 2012;21(1):82-91.
2012: C G Niels Vos; Max Dahele; Chris Dickhoff; Marinus A Paul; Egbert F Smit; Koen J Hartemink
[Treatment and prognosis of superior sulcus tumours].
Nederlands tijdschrift voor geneeskunde 2012;156(49):A5419.
2012: Anne-Marie H Krebber; C René Leemans; Egbert F Smit; Filip Smit; Annemieke van Straten; Annemarie Becker; Aartjan T F Beekman; Pim Cuijpers; Remco de Bree; Guus M Eeckhout; Irma M Verdonck-de Leeuw
Stepped care targeting psychological distress in head and neck and lung cancer patients: a randomized clinical trial.
BMC cancer 2012;12():173.
2011: Erik C J Phernambucq; Egbert F Smit; Andrew Vincent; David A Palma; Suresh Senan
Time and dose-related changes in radiological lung density after concurrent chemoradiotherapy for lung cancer.
Lung cancer (Amsterdam, Netherlands) 2011;74(3):451-6.
2011: Wouter W Mellema; Egbert F Smit; Anne-Marie C Dingemans
Low molecular weight heparins in the treatment of lung cancer.
Expert opinion on investigational drugs 2011;20(11):1517-22.
2011: A Becker; L Crombag; D A M Heideman; P E Postmus; F B Thunnissen; A W van Wijk; Egbert F Smit
Retreatment with erlotinib: Regain of TKI sensitivity following a drug holiday for patients with NSCLC who initially responded to EGFR-TKI treatment.
European journal of cancer (Oxford, England : 1990) 2011;47(17):2603-6.
2011: John T Maringwa; Francesca Martinelli; David Osoba; Chantal Quinten; Bryce B Reeve; Jolie Ringash; Egbert F Smit; Martin J Taphoorn; Jan P van Meerbeeck; Jurgen Vercauteren; Joachim Weis; Andrew Bottomley; Charles S Cleeland; Corneel Coens; Henning Flechtner; Carolyn C Gotay; Elfriede Greimel; Madeleine King; Joseph Schmucker-Von Koch
Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2011;19(11):1753-60.
2011: Astrid A M van der Veldt; Adriaan A Lammertsma; Mark Lubberink; Egbert F Smit
Comment on Cho et al.: Usefulness of FDG PET/CT in determining benign from malignant endobronchial obstruction.
European radiology 2011;21(10):2148-9; author reply 2150.
2011: Dorian R A Swarts; Frederik B J M Thunnissen; Robert-Jan van Suylen; Aryan Vink; S M H Claessen; Wouter W de Herder; Ronald R de Krijger; Anne-Marie C Dingemans; Y M H Jonkers; Aurel Perren; Frans C S Ramaekers; Cornelis A Seldenrijk; Egbert F Smit; Ernst J M Speel
Deletions of 11q22.3-q25 are associated with atypical lung carcinoids and poor clinical outcome.
The American journal of pathology 2011;179(3):1129-37.
2011: Barbara S van der Meij; Paul A M van Leeuwen; Geert M Fieten; Marinus A Paul; Erik C J Phernambucq; Egbert F Smit; J Wolter A Oosterhuis
Nutrition during trimodality treatment in stage III non-small cell lung cancer: not only important for underweight patients.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(9):1563-8.
2011: Floris H P van Velden; Maqsood Yaqub; Patsuree Cheebsumon; Otto S Hoekstra; Adriaan A Lammertsma; Egbert F Smit; Ronald Boellaard
Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies.
European journal of nuclear medicine and molecular imaging 2011;38(9):1636-47.
2011: Astrid A M van der Veldt; Arthur van Lingen; Albert D Windhorst; Maqsood Yaqub; Emile F I Comans; Henri N Greuter; N Harry Hendrikse; Gerarda J Herder; Mark Lubberink; Martien P J Mooijer; Anneloes Y Rijnders; S Nafees Rizvi; Robert C Schuit; Egbert F Smit; Adriaan A Lammertsma
Absolute quantification of [(11)C]docetaxel kinetics in lung cancer patients using positron emission tomography.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(14):4814-24.
2011: Remco M van den Berg; Peter J F Snijders; Katrien Grunberg; Clarissa Kooi; Marieke D Spreeuwenberg; Chris J L M Meijer; Pieter E Postmus; Egbert F Smit; Renske D M Steenbergen
Comprehensive CADM1 promoter methylation analysis in NSCLC and normal lung specimens.
Lung cancer (Amsterdam, Netherlands) 2011;72(3):316-21.
2011: Patsuree Cheebsumon; Linda M Velasquez; Corneline Hoekstra; Wendy Hayes; Reina W Kloet; Nikie J Hoetjes; Egbert F Smit; Otto S Hoekstra; Adriaan A Lammertsma; Ronald Boellaard
Measuring response to therapy using FDG PET: semi-quantitative and full kinetic analysis.
European journal of nuclear medicine and molecular imaging 2011;38(5):832-42.
2011: A-M C Dingemans; Joop de Langen; V van den Boogaart; J Tim Marcus; W H Backes; H T G M Scholtens; Harm van Tinteren; Otto S Hoekstra; Jan Pruim; B Brans; F B Thunnissen; Egbert F Smit; Harry J M Groen
First-line erlotinib and bevacizumab in patients with locally advanced and/or metastatic non-small-cell lung cancer: a phase II study including molecular imaging.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(3):559-66.
2011: Joline S W Lind; Frank J Lagerwaard; Egbert F Smit; Pieter E Postmus; Ben Slotman; Suresh Senan
Time for reappraisal of extracranial treatment options? Synchronous brain metastases from nonsmall cell lung cancer.
Cancer 2011;117(3):597-605.
2011: Maria J Overbeek; Egbert F Smit; Maria P A van Berkel; Madelon C Vonk; Anton Vonk-Noordegraaf; Alexandre E Voskuyl; a boonstra; Ben A C Dijkmans; Laurens S Hondema; Wolter J Mooi; Katrien Grunberg
Platelet-derived growth factor receptor-β and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: a case-control study.
Arthritis research & therapy 2011;13(2):R61.
2011: Erik Thunnissen; petra nederlof; Egbert F Smit; Anne-Marie C Dingemans
[EGFR-mutation in non-small cell lung carcinoma. Treatment with tyrosine kinase inhibitors possible].
Nederlands tijdschrift voor geneeskunde 2011;155():A2554.
2011: Joop de Langen; Vivian van den Boogaart; Mark Lubberink; Walter H Backes; J Tim Marcus; Harm van Tinteren; Jan Pruim; Boudewijn Brans; Pieter Leffers; Anne-Marie C Dingemans; Egbert F Smit; Harry J M Groen; Otto S Hoekstra
Monitoring response to antiangiogenic therapy in non-small cell lung cancer using imaging markers derived from PET and dynamic contrast-enhanced MRI.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(1):48-55.
2011: E C J Phernambucq; F O B Spoelstra; W F A R Verbakel; Pieter E Postmus; C F Melissant; K I Maassen van den Brink; V Frings; P M van de Ven; Egbert F Smit; Suresh Senan
Outcomes of concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer and significant comorbidity.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(1):132-8.
2010: Virginie Frings; Joop de Langen; Egbert F Smit; Floris H P van Velden; Otto S Hoekstra; Harm van Tinteren; Ronald Boellaard
Repeatability of metabolically active volume measurements with 18F-FDG and 18F-FLT PET in non-small cell lung cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(12):1870-7.
2010: Joline S W Lind; Martijn R Meijerink; Anne-Marie C Dingemans; Cornelis van Kuijk; Michel C Ollers; Dirk De Ruysscher; Pieter E Postmus; Egbert F Smit
Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?
European radiology 2010;20(12):2890-8.
2010: Astrid A M van der Veldt; N Harry Hendrikse; Hendrik J Harms; Emile F I Comans; Pieter E Postmus; Egbert F Smit; Adriaan A Lammertsma; Mark Lubberink
Quantitative parametric perfusion images using 15O-labeled water and a clinical PET/CT scanner: test-retest variability in lung cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(11):1684-90.
2010: denis moro-sibilot; Alain Vergnenegre; Egbert F Smit; elizabeth toy; Barbara Parente; Stephan Schmitz; Kees Kraaij; Carla Visseren-Grul; Victoria Soldatenkova; Jorge Arellano; Claudia Leteneux
Second-line therapy for NSCLC in clinical practice: baseline results of the European SELECTTION observational study.
Current medical research and opinion 2010;26(11):2661-72.
2010: Klaartje W Maas; Sherif Y El-Sharouni; Erik C J Phernambucq; Jos A Stigt; Harry J M Groen; Gerarda J M Herder; Ben E E M Van Den Borne; Suresh Senan; Marinus A Paul; Egbert F Smit; Franz Schramel
Weekly chemoradiation (docetaxel/cisplatin) followed by surgery in stage III NSCLC; a multicentre phase II study.
Anticancer research 2010;30(10):4237-43.
2010: Barbara S van der Meij; Jacqueline A E Langius; Egbert F Smit; Marieke D Spreeuwenberg; B Mary E von Blomberg; Annemieke C Heijboer; Marinus A Paul; Paul A M van Leeuwen
Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment.
The Journal of nutrition 2010;140(10):1774-80.
2010: Astrid A M van der Veldt; N Harry Hendrikse; Egbert F Smit; Martien P J Mooijer; Anneloes Y Rijnders; Winald Gerritsen; Jacobus J M van Der Hoeven; Albert D Windhorst; Adriaan A Lammertsma; Mark Lubberink
Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients.
European journal of nuclear medicine and molecular imaging 2010;37(10):1950-8.
2010: Wieneke A Buikhuisen; Jacobus A Burgers; Andrew D Vincent; Jan H M Schellens; Jos H Beijnen; Egbert F Smit; Markus Joerger
Pemetrexed pathway-associated germline polymorphisms: a useful tool for treatment individualization?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(27):e482-3; author reply e484.
2010: Annemarie Becker; Atie van Wijk; Egbert F Smit; Pieter E Postmus
Side-effects of long-term administration of erlotinib in patients with non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(9):1477-80.
2010: Veerle F M Surmont; Egbert F Smit; M de Jonge; Joachim G J V Aerts; Kristiaan Nackaerts; R Vernhout; J Gras; A Van Wijk; E C J Phernambucq; Jan P van Meerbeeck; Suresh Senan; C J Kraaij; N Chouaki; J Praag; Rob J van Klaveren
Pemetrexed and cisplatin with concurrent radiotherapy for locally advanced non-small cell and limited disease small cell lung cancer: results from 2 phase I studies.
Lung cancer (Amsterdam, Netherlands) 2010;69(3):302-6.
2010: Remco M Van den Berg; Hes Brokx; Aurélien Vesin; John Field; Christian Brambilla; Chris J L M Meijer; G Thomas Sutedja; Daniëlle A M Heideman; Pieter E Postmus; Egbert F Smit; Peter J F Snijders
Prognostic value of hTERT mRNA expression in surgical samples of lung cancer patients: the European Early Lung Cancer Project.
International journal of oncology 2010;37(2):455-61.
2010: Romane M Schook; Berber B M Postmus; Remco M van den Berg; Tom G Sutedja; Frances S Man de; Egbert F Smit; Pieter E Postmus
The finding of premalignant lesions is not associated with smoking cessation in chemoprevention study volunteers.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(8):1240-5.
2010: Joline S W Lind; Anne-Marie C Dingemans; Harry J M Groen; Frederik B Thunnissen; Otto Bekers; Daniëlle A M Heideman; Richard J Honeywell; Elisa Giovannetti; Godefridus J Peters; Pieter E Postmus; Robert Jan van Suylen; Egbert F Smit
A multicenter phase II study of erlotinib and sorafenib in chemotherapy-naive patients with advanced non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(11):3078-87.
2010: Egbert F Smit; Anne-Marie C Dingemans; Frederik B Thunnissen; Monique M Hochstenbach; Robert-Jan van Suylen; Pieter E Postmus
Sorafenib in patients with advanced non-small cell lung cancer that harbor K-ras mutations: a brief report.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(5):719-20.
2010: Joline S W Lind; Pieter E Postmus; Egbert F Smit
Osteoblastic bone lesions developing during treatment with erlotinib indicate major response in patients with non-small cell lung cancer: a brief report.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(4):554-7.
2010: Elisa Giovannetti; Paolo A Zucali; Godefridus J Peters; Filippo Cortesi; Armida D'Incecco; Egbert F Smit; Alfredo Falcone; Jacobus A Burgers; Armando Santoro; Romano Danesi; Giuseppe Giaccone; Carmelo Tibaldi
Association of polymorphisms in AKT1 and EGFR with clinical outcome and toxicity in non-small cell lung cancer patients treated with gefitinib.
Molecular cancer therapeutics 2010;9(3):581-93.
2010: Massimo Di Maio; Nicola Lama; Alessandro Morabito; Egbert F Smit; Vassilis Georgoulias; Koji Takeda; Elisabeth Quoix; Dora Hatzidaki; Floris M Wachters; Vittorio Gebbia; Chun-Ming Tsai; Carlos Camps; Wolfgang Schuette; Paolo Chiodini; Maria Carmela Piccirillo; Francesco Perrone; Ciro Gallo; Cesare Gridelli
Clinical assessment of patients with advanced non-small-cell lung cancer eligible for second-line chemotherapy: a prognostic score from individual data of nine randomised trials.
European journal of cancer (Oxford, England : 1990) 2010;46(4):735-43.
2010: L Vroling; J S W Lind; R R de Haas; Hendrik Verheul; V W M van Hinsbergh; Henk J Broxterman; Egbert F Smit
CD133+ circulating haematopoietic progenitor cells predict for response to sorafenib plus erlotinib in non-small cell lung cancer patients.
British journal of cancer 2010;102(2):268-75.
2010: Maria J Overbeek; Koen T B Mouchaers; Hans M Niessen; Awal M Hadi; Koba Kupreishvili; Anco Boonstra; Alexandre E Voskuyl; Jeroen A M Belien; Egbert F Smit; Ben C Dijkmans; Anton Vonk-Noordegraaf; Katrien Grunberg
Characteristics of interstitial fibrosis and inflammatory cell infiltration in right ventricles of systemic sclerosis-associated pulmonary arterial hypertension.
International journal of rheumatology 2010;2010():.
2009: Joline S W Lind; Pieter E Postmus; Daniëlle A M Heideman; Erik B Thunnissen; Otto Bekers; Egbert F Smit
Dramatic response to low-dose erlotinib of epidermal growth factor receptor mutation-positive recurrent non-small cell lung cancer after severe cutaneous toxicity.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009;4(12):1585-6.
2009: Erik C J Phernambucq; Femke O B Spoelstra; Marinus A Paul; Suresh Senan; Christian F Melissant; Pieter E Postmus; Egbert F Smit
Evaluation of a treatment strategy for optimising preoperative chemoradiotherapy in stage III non-small-cell lung cancer.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2009;36(6):1052-7.
2009: Niels B Pronk; Albert J Polman; Lotus Sterk; Jan W A Oosterhuis; Egbert F Smit
A nonresponding small cell lung carcinoma.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009;4(10):1291-2.
2009: Mark A Socinski; Egbert F Smit; Paul Lorigan; Kartik Konduri; Martin Reck; Aleksandra Szczesna; Johnetta Blakely; Piotr Serwatowski; Nina A Karaseva; tudor ciuleanu; Jacek Jassem; Mircea Dediu; Shengyan Hong; Carla Visseren-Grul; Axel-Rainer Hanauske; Coleman K Obasaju; Susan C Guba; Nick Thatcher
Phase III study of pemetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensive-stage small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(28):4787-92.
2009: Joline S W Lind; Egbert F Smit
Angiogenesis inhibitors in the treatment of non-small cell lung cancer.
Therapeutic advances in medical oncology 2009;1(2):95-107.
2009: Joline S W Lind; Frank J Lagerwaard; Egbert F Smit; Suresh Senan
Phase I study of concurrent whole brain radiotherapy and erlotinib for multiple brain metastases from non-small-cell lung cancer.
International journal of radiation oncology, biology, physics 2009;74(5):1391-6.
2009: Maria J Overbeek; M C Vonk; a boonstra; Alexandre E Voskuyl; Anton Vonk-Noordegraaf; Egbert F Smit; B A C Dijkmans; Pieter E Postmus; Wolter J Mooi; Y Heijdra; Katrien Grunberg
Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy.
The European respiratory journal 2009;34(2):371-9.
2009: Egbert F Smit; Sjaak A Burgers; Bonne Biesma; Hans J M Smit; Pier Eppinga; Anne-Marie C Dingemans; Markus Joerger; Jan H Schellens; Andrew Vincent; nico van zandwijk; Harry J M Groen
Randomized phase II and pharmacogenetic study of pemetrexed compared with pemetrexed plus carboplatin in pretreated patients with advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(12):2038-45.
2009: Massimo Di Maio; Paolo Chiodini; Vassilis Georgoulias; Dora Hatzidaki; Koji Takeda; Floris M Wachters; Vittorio Gebbia; Egbert F Smit; Alessandro Morabito; Ciro Gallo; Francesco Perrone; Cesare Gridelli
Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(11):1836-43.
2009: Joop de Langen; Bianca Klabbers; Mark Lubberink; Ronald Boellaard; Marieke D Spreeuwenberg; Ben Slotman; Remco de Bree; Egbert F Smit; Otto S Hoekstra; Adriaan A Lammertsma
Reproducibility of quantitative 18F-3'-deoxy-3'-fluorothymidine measurements using positron emission tomography.
European journal of nuclear medicine and molecular imaging 2009;36(3):389-95.
2009: M I Galleges Ruiz; Karijn Floor; S M Steinberg; Katrien Grunberg; F B J M Thunnissen; J A M Belien; Gerrit A Meijer; Godefridus J Peters; Egbert F Smit; Jose A Rodriguez; Giuseppe Giaccone
Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients.
British journal of cancer 2009;100(1):145-52.
2009: D A M Heideman; F B Thunnissen; M Doeleman; Duco Kramer; Hendrik Verheul; Egbert F Smit; Pieter E Postmus; C J L M Meijer; Gerrit A Meijer; P J F Snijders
A panel of high resolution melting (HRM) technology-based assays with direct sequencing possibility for effective mutation screening of EGFR and K-ras genes.
Cellular oncology : the official journal of the International Society for Cellular Oncology 2009;31(5):329-33.
2009: Duco Kramer; F B Thunnissen; Mariëlle I Gallegos-Ruiz; Egbert F Smit; Pieter E Postmus; C J L M Meijer; P J F Snijders; D A M Heideman
A fast, sensitive and accurate high resolution melting (HRM) technology-based assay to screen for common K-ras mutations.
Cellular oncology : the official journal of the International Society for Cellular Oncology 2009;31(3):161-7.
2009: Paul Roepman; Jacek Jassem; Egbert F Smit; Thomas Muley; Jacek Niklinski; Tony van de Velde; Anke T Witteveen; Witold Rzyman; Arno Floore; Sjaak Burgers; Giuseppe Giaccone; Michael Meister; Hendrik Dienemann; Marcin Skrzypski; Miroslaw Kozlowski; Wolter J Mooi; nico van zandwijk
An immune response enriched 72-gene prognostic profile for early-stage non-small-cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(1):284-90.
2008: Joop de Langen; Mark Lubberink; Ronald Boellaard; Marieke D Spreeuwenberg; Egbert F Smit; Otto S Hoekstra; Adriaan A Lammertsma
Reproducibility of tumor perfusion measurements using 15O-labeled water and PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(11):1763-8.
2008: Egbert F Smit
Thymic malignancies.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19 Suppl 7():vii309-12.
2008: Joline S W Lind; Egbert F Smit; Katrien Grunberg; Suresh Senan; Frank J Lagerwaard
Fatal interstitial lung disease after erlotinib for non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(9):1050-3.
2008: Maria J Overbeek; Geerten P van Nieuw Amerongen; a boonstra; Egbert F Smit; Anton Vonk-Noordegraaf
Possible role of imatinib in clinical pulmonary veno-occlusive disease.
The European respiratory journal 2008;32(1):232-5.
2008: Maria J Overbeek; Jan-Willem Lankhaar; Nico Westerhof; A E Voskuyl; a boonstra; J G F Bronzwaer; K M J Marques; Egbert F Smit; B A C Dijkmans; Anton Vonk-Noordegraaf
Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension.
The European respiratory journal 2008;31(6):1160-6.
2008: Remco M van den Berg; H Jelle Teertstra; nico van zandwijk; Harm van Tinteren; Christien Visser; Arifa Pasic; Tom G Sutedja; Paul Baas; Richard P Golding; Pieter E Postmus; Egbert F Smit
CT detected indeterminate pulmonary nodules in a chemoprevention trial of fluticasone.
Lung cancer (Amsterdam, Netherlands) 2008;60(1):57-61.
2008: Cornelis J A Haasbeek; Suresh Senan; Egbert F Smit; Marinus A Paul; Ben Slotman; Frank J Lagerwaard
Critical review of nonsurgical treatment options for stage I non-small cell lung cancer.
The oncologist 2008;13(3):309-19.
2008: Frank J Lagerwaard; Cornelis J A Haasbeek; Egbert F Smit; Ben Slotman; Suresh Senan
Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer.
International journal of radiation oncology, biology, physics 2008;70(3):685-92.
2008: Maria J Overbeek; Herman Groepenhoff; Alexandre E Voskuyl; Egbert F Smit; Jochem W L Peeters; Anton Vonk-Noordegraaf; Marieke D Spreeuwenberg; Ben C Dijkmans; a boonstra
Membrane diffusion- and capillary blood volume measurements are not useful as screening tools for pulmonary arterial hypertension in systemic sclerosis: a case control study.
Respiratory research 2008;9():68.
2008: Mariëlle I Gallegos-Ruiz; Karijn Floor; Paul Roepman; José A Rodriguez; Gerrit A Meijer; Wolter J Mooi; Ewa Jassem; Jacek Niklinski; Thomas Muley; nico van zandwijk; Egbert F Smit; Kristin Beebe; Len Neckers; Bauke Ylstra; Giuseppe Giaccone
Integration of gene dosage and gene expression in non-small cell lung cancer, identification of HSP90 as potential target.
PloS one 2008;3(3):e0001722.
2008: Cornelis J A Haasbeek; Suresh Senan; Egbert F Smit; Frank J Lagerwaard
CT-guided pulmonary radiofrequency ablation.
Radiology 2008;246(1):334-5; author reply 334-5.
2007: Anke W J Roenhorst; Alfons C M van den Bergh; John W G van Putten; Egbert F Smit
Iris metastasis in small-cell lung carcinoma.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(12):1128-9.
2007: Wouter K de Jong; Harry J M Groen; Mia G J Koolen; Bonne Biesma; Luuk N A Willems; Hian-Bie Kwa; Aart van Bochove; Harm van Tinteren; Egbert F Smit
Phase III study of cyclophosphamide, doxorubicin, and etoposide compared with carboplatin and paclitaxel in patients with extensive disease small-cell lung cancer.
European journal of cancer (Oxford, England : 1990) 2007;43(16):2345-50.
2007: Peter W A Kunst; Pyng Lee; Marinus A Paul; Suresh Senan; Egbert F Smit
Restaging of mediastinal nodes with transbronchial needle aspiration after induction chemoradiation for locally advanced non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(10):912-5.
2007: Mikael E Craanen; Emile F I Comans; Marinus A Paul; Egbert F Smit
Endoscopic ultrasound guided fine-needle aspiration and 18FDG-positron emission tomography in the evaluation of patients with non-small cell lung cancer.
Interactive cardiovascular and thoracic surgery 2007;6(4):433-6.
2007: Klaartje W Maas; Sherif Y El-Sharouni; Egbert F Smit; Franz Schramel
Sequencing chemotherapy, radiotherapy and surgery in combined modality treatment of stage III nonsmall cell lung cancer.
Current opinion in pulmonary medicine 2007;13(4):297-304.
2007: Johannes Voortman; Egbert F Smit; Richard Honeywell; Bart C Kuenen; Godefridus J Peters; Helgi van de Velde; Giuseppe Giaccone
A parallel dose-escalation study of weekly and twice-weekly bortezomib in combination with gemcitabine and cisplatin in the first-line treatment of patients with advanced solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(12):3642-51.
2007: Remco M van den Berg; Harm van Tinteren; nico van zandwijk; Christine Visser; Arifa Pasic; Clarissa Kooi; Tom G Sutedja; Paul Baas; Katrien Grunberg; Wolter J Mooi; Peter J F Snijders; Pieter E Postmus; Egbert F Smit
The influence of fluticasone inhalation on markers of carcinogenesis in bronchial epithelium.
American journal of respiratory and critical care medicine 2007;175(10):1061-5.
2007: Suresh Senan; Egbert F Smit
Design of clinical trials of radiation combined with antiangiogenic therapy.
The oncologist 2007;12(4):465-77.
2007: Jan P van Meerbeeck; Gijsbert W P M Kramer; Paul E Y Van Schil; Catherine Legrand; Egbert F Smit; Franz Schramel; Vivianne C G Tjan-Heijnen; Bonne Biesma; Channa Debruyne; nico van zandwijk; Ted A W Splinter; Giuseppe Giaccone
Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
Journal of the National Cancer Institute 2007;99(6):442-50.
2007: Suresh Senan; Niels J A Haasbeek; Egbert F Smit; Frank J Lagerwaard
Stereotactic radiotherapy for centrally located early-stage lung tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(4):464; author reply 465.
2007: Mariëlle I Gallegos-Ruiz; Hester van Cruijsen; Egbert F Smit; Katrien Grunberg; Gerrit A Meijer; Jose A Rodriguez; Bauke Ylstra; Giuseppe Giaccone
Genetic heterogeneity in patients with multiple neoplastic lung lesions: a report of three cases.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(1):12-21.
2006: Margaretha van der Deen; Hendrik Marks; B W M Willemse; Dirkje S Postma; Michael Müller; Egbert F Smit; George L Scheffer; Rik J Scheper; Elisabeth G E de Vries; Wim Timens
Diminished expression of multidrug resistance-associated protein 1 (MRP1) in bronchial epithelium of COPD patients.
Virchows Archiv : an international journal of pathology 2006;449(6):682-8.
2006: Fabio Efficace; andrew bottomley; Egbert F Smit; Pilar Lianes; Catherine Legrand; Channa Debruyne; Franz Schramel; Hans J M Smit; Rabab Mohamed Gaafar; Bonne Biesma; Christian Manegold; Corneel Coens; Giuseppe Giaccone; Jan P van Meerbeeck
Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(11):1698-704.
2006: Judith R Kroep; Egbert F Smit; Giuseppe Giaccone; Kasper van der Born; Jos H Beijnen; Cees J van Groeningen; Wim J F van der Vijgh; Pieter E Postmus; HERBERT PINEDO; Godefridus J Peters
Pharmacology of the paclitaxel-cisplatin, gemcitabine-cisplatin, and paclitaxel-gemcitabine combinations in patients with advanced non-small cell lung cancer.
Cancer chemotherapy and pharmacology 2006;58(4):509-16.
2006: E C J Phernambucq; Bonne Biesma; Egbert F Smit; Marinus A Paul; A vd Tol; Franz Schramel; R J Bolhuis; Pieter E Postmus
Multicenter phase II trial of accelerated cisplatin and high-dose epirubicin followed by surgery or radiotherapy in patients with stage IIIa non-small-cell lung cancer with mediastinal lymph node involvement (N2-disease).
British journal of cancer 2006;95(4):470-4.
2006: Gijsbert W P M Kramer; Catherine L Legrand; Paul Van Schil; Lon Uitterhoeve; Egbert F Smit; Franz Schramel; Bonne Biesma; Vivianne C G Tjan-Heijnen; nico van zandwijk; Ted A W Splinter; Giuseppe Giaccone; Jan P van Meerbeeck
Quality assurance of thoracic radiotherapy in EORTC 08941: a randomised trial of surgery versus thoracic radiotherapy in patients with stage IIIA non-small-cell lung cancer (NSCLC) after response to induction chemotherapy.
European journal of cancer (Oxford, England : 1990) 2006;42(10):1391-8.
2006: Gerarda J Herder; Henk Kramer; Otto S Hoekstra; Egbert F Smit; Jan Pruim; Harm van Tinteren; Emile F I Comans; Paul Verboom; Carin A Uyl-de Groot; Alle Welling; Marinus A Paul; Maarten Boers; Pieter E Postmus; Gerrit J J Teule; Harry J M Groen
Traditional versus up-front [18F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(12):1800-6.
2006: Luis Paz-Ares; Jean-Yves Douillard; Piotr Koralewski; Christian Manegold; Egbert F Smit; José Miguel Reyes; Gee-Chen Chang; William J John; Patrick M Peterson; Coleman K Obasaju; Michael Lahn; David R Gandara
Phase III study of gemcitabine and cisplatin with or without aprinocarsen, a protein kinase C-alpha antisense oligonucleotide, in patients with advanced-stage non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(9):1428-34.
2005: Corneline Hoekstra; Sigrid Stroobants; Egbert F Smit; Johan Vansteenkiste; Harm van Tinteren; Pieter E Postmus; Richard P Golding; Bonne Biesma; Frans J H M Schramel; nico van zandwijk; Adriaan A Lammertsma; Otto S Hoekstra
Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(33):8362-70.
2005: Gerarda J Herder; Harm van Tinteren; Richard P Golding; Piet J Kostense; Emile F I Comans; Egbert F Smit; Otto S Hoekstra
Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography.
Chest 2005;128(4):2490-6.
2005: Roderick H J Breuer; Peter J F Snijders; GT Sutedja; Richard G A B Sewalt; Arie P Otte; Pieter E Postmus; C J L M Meijer; Frank M Raaphorst; Egbert F Smit
Expression of the p16(INK4a) gene product, methylation of the p16(INK4a) promoter region and expression of the polycomb-group gene BMI-1 in squamous cell lung carcinoma and premalignant endobronchial lesions.
Lung cancer (Amsterdam, Netherlands) 2005;48(3):299-306.
2005: Harm van Tinteren; Egbert F Smit; Otto S Hoekstra
FDG-PET in addition to conventional work-up in non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(7):1591; author reply 1591-2.
2005: Floris M Wachters; Harry J M Groen; Bonne Biesma; Franz Schramel; Pieter E Postmus; J A Stigt; Egbert F Smit
A randomised phase II trial of docetaxel vs docetaxel and irinotecan in patients with stage IIIb-IV non-small-cell lung cancer who failed first-line treatment.
British journal of cancer 2005;92(1):15-20.
2005: Roderick H J Breuer; Arifa Pasic; Egbert F Smit; Esther van Vliet; Anton Vonk-Noordegraaf; Elle J Risse; Pieter E Postmus; Tom G Sutedja
The natural course of preneoplastic lesions in bronchial epithelium.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(2 Pt 1):537-43.
2005: Niels Neymark; Pilar Lianes; Egbert F Smit; Jan P van Meerbeeck
Economic evaluation of three two-drug chemotherapy regimens in advanced non-small-cell lung cancer.
PharmacoEconomics 2005;23(11):1155-66.
2004: Roderick H J Breuer; Peter J F Snijders; Egbert F Smit; Tom G Sutedja; Richard G A B Sewalt; Arie P Otte; Folkert J van Kemenade; Pieter E Postmus; Chris J L M Meijer; Frank M Raaphorst
Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesis.
Neoplasia (New York, N.Y.) 2004;6(6):736-43.
2004: Gerarda J Herder; Richard P Golding; Otto S Hoekstra; Emile F I Comans; Gerrit J J Teule; Pieter E Postmus; Egbert F Smit
The performance of( 18)F-fluorodeoxyglucose positron emission tomography in small solitary pulmonary nodules.
European journal of nuclear medicine and molecular imaging 2004;31(9):1231-6.
2004: Giuseppe Giaccone; J L González-Larriba; A T van Oosterom; R Alfonso; Egbert F Smit; M Martens; Godefridus J Peters; Wim J F van der Vijgh; R Smith; Steven D Averbuch; Abderrahim Fandi
Combination therapy with gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, gemcitabine and cisplatin in patients with advanced solid tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(5):831-8.
2004: Peter J F Snijders; Roderick H J Breuer; Tom G Sutedja; Monique Egging; Feja J Voorhorst; Renske D M Steenbergen; Hans C van der Linden; Elle K J Risse; Johannes Berkhof; Elisabeth G E de Vries; Ate G J van der Zee; Pieter E Postmus; Chris J L M Meijer; Egbert F Smit
Elevated hTERT mRNA levels: A potential determinant of bronchial squamous cell carcinoma (in situ).
International journal of cancer. Journal international du cancer 2004;109(3):412-7.
2004: Giuseppe Giaccone; Egbert F Smit; M de Jonge; E Dansin; Evangelos Briasoulis; Andrea Ardizzoni; Jean-Yves Douillard; Dominique Spaeth; D Lacombe; B Baron; P Bachmann; Pierre Fumoleau
Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer; a phase II trial of the EORTC-New Drug Development Group.
European journal of cancer (Oxford, England : 1990) 2004;40(5):667-72.
2003: Egbert F Smit; Jan P van Meerbeeck; Pilar Lianes; Channa Debruyne; Catherine Legrand; Franz Schramel; Hans Smit; Rabab Mohamed Gaafar; Bonne Biesma; Chris Manegold; Niels Neymark; Giuseppe Giaccone
Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group--EORTC 08975.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(21):3909-17.
2003: Paul Verboom; Harm van Tinteren; Otto S Hoekstra; Egbert F Smit; Jan H A M van den Bergh; Ad J M Schreurs; Roland A L M Stallaert; Piet C M van Velthoven; Emile F I Comans; Fred W Diepenhorst; Johan C van Mourik; Pieter E Postmus; Maarten Boers; E W M Grijseels; Gerrit J J Teule; Carin A Uyl-de Groot
Cost-effectiveness of FDG-PET in staging non-small cell lung cancer: the PLUS study.
European journal of nuclear medicine and molecular imaging 2003;30(11):1444-9.
2003: M E R O'Brien; Ted A W Splinter; Egbert F Smit; Bonne Biesma; Maciej Krzakowski; Vivianne C G Tjan-Heijnen; Aart van Bochove; J Stigt; M J A Smid-Geirnaerdt; Channa Debruyne; Catherine Legrand; Giuseppe Giaccone
Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer. an EORTC phase II study (EORTC 08958).
European journal of cancer (Oxford, England : 1990) 2003;39(10):1416-22.
2003: Rafal Dziadziuszko; Andrea Ardizzoni; Pieter E Postmus; Egbert F Smit; A Price; Channa Debruyne; Catherine Legrand; Giuseppe Giaccone
Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases. a phase II study of the EORTC Lung Cancer Group (08965).
European journal of cancer (Oxford, England : 1990) 2003;39(9):1271-6.
2003: Roderick H J Breuer; Peter J F Snijders; Tom G Sutedja; Hans v d Linden; Elle K J Risse; Chris J L M Meijer; Pieter E Postmus; Egbert F Smit
Suprabasal p53 immunostaining in premalignant endobronchial lesions in combination with histology is associated with bronchial cancer.
Lung cancer (Amsterdam, Netherlands) 2003;40(2):165-72.
2003: Egbert F Smit; Karin Mattson; Joachim von Pawel; Christian Manegold; S Clarke; Pieter E Postmus
ALIMTA (pemetrexed disodium) as second-line treatment of non-small-cell lung cancer: a phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(3):455-60.
2003: Corneline Hoekstra; Sigrid Stroobants; Otto S Hoekstra; Johan Vansteenkiste; Bonne Biesma; F J H M Schramel; nico van zandwijk; Harm van Tinteren; Egbert F Smit
The value of [18F]fluoro-2-deoxy-D-glucose positron emission tomography in the selection of patients with stage IIIA-N2 non-small cell lung cancer for combined modality treatment.
Lung cancer (Amsterdam, Netherlands) 2003;39(2):151-7.
2003: Andrea Ardizzoni; Christian Manegold; Channa Debruyne; Rabab Mohamed Gaafar; Erika Buchholz; Egbert F Smit; Pilar Lianes; Guul P M ten Velde; Lionel Bosquee; Catherine Legrand; Carlo Emanuele Neumaier; Kathrine King
European organization for research and treatment of cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1):143-50.
2003: Gerarda J Herder; Harm van Tinteren; Emile F I Comans; Otto S Hoekstra; Gerrit J J Teule; Pieter E Postmus; Urvi Joshi; Egbert F Smit
Prospective use of serial questionnaires to evaluate the therapeutic efficacy of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) in suspected lung cancer.
Thorax 2003;58(1):47-51.
2002: Corneline Hoekstra; Otto S Hoekstra; Sigrid Stroobants; Johan Vansteenkiste; Johan Nuyts; Egbert F Smit; Maarten Boers; Jos W R Twisk; Adriaan A Lammertsma
Methods to monitor response to chemotherapy in non-small cell lung cancer with 18F-FDG PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2002;43(10):1304-9.
2002: Corneline Hoekstra; Sigrid Stroobants; Otto S Hoekstra; Egbert F Smit; Johan Vansteenkiste; Adriaan A Lammertsma
Measurement of perfusion in stage IIIA-N2 non-small cell lung cancer using H(2)(15)O and positron emission tomography.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(7):2109-15.
2002: Harm van Tinteren; Otto S Hoekstra; Egbert F Smit; Jan H A M van den Bergh; Ad J M Schreurs; Roland A L M Stallaert; Piet C M van Velthoven; Emile F I Comans; Fred W Diepenhorst; Paul Verboom; Johan C van Mourik; Pieter E Postmus; Maarten Boers; Gerrit J J Teule
Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial.
Lancet 2002;359(9315):1388-93.
2002: Jan P van Meerbeeck; Paul Baas; Channa Debruyne; Egbert F Smit; Rob J van Klaveren; D Galdermans; M A Lentz; Christian Manegold; Giuseppe Giaccone
A phase II EORTC study of temozolomide in patients with malignant pleural mesothelioma.
European journal of cancer (Oxford, England : 1990) 2002;38(6):779-83.
2002: Bart C Kuenen; Lee Rosen; Egbert F Smit; Mandy R N Parson; Marcel Levi; Rita Ruijter; Holger Huisman; Marc A Kedde; Paul Noordhuis; Wim J F van der Vijgh; Godefridus J Peters; Gillian F Cropp; Paul Scigalla; Klaas Hoekman; HERBERT PINEDO; Giuseppe Giaccone
Dose-finding and pharmacokinetic study of cisplatin, gemcitabine, and SU5416 in patients with solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(6):1657-67.
2002: Cynthia Huisman; Carlos G Ferreira; Linda E Bröker; Jose A Rodriguez; Egbert F Smit; Pieter E Postmus; Frank A E Kruyt; Giuseppe Giaccone
Paclitaxel triggers cell death primarily via caspase-independent routes in the non-small cell lung cancer cell line NCI-H460.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(2):596-606.
2002: Giuseppe Giaccone; Egbert F Smit
Update on the systemic treatment of lung cancer.
Cancer chemotherapy and biological response modifiers 2002;20():697-716.
2002: Paul Verboom; G Judith M Herder; Otto S Hoekstra; Egbert F Smit; Jan H A M van den Bergh; Piet C M van Velthoven; E W M Grijseels
Staging of non-small-cell lung cancer and application of FDG-PET. A cost modeling approach.
International journal of technology assessment in health care 2002;18(3):576-85.
2002: Gerarda J Herder; Paul Verboom; Egbert F Smit; Piet C M van Velthoven; Jan H A M van den Bergh; C D Colder; I van Mansom; Johan C van Mourik; Pieter E Postmus; Gerrit J J Teule; Otto S Hoekstra
Practice, efficacy and cost of staging suspected non-small cell lung cancer: a retrospective study in two Dutch hospitals.
Thorax 2002;57(1):11-4.
2001: Cynthia Huisman; Bonne Biesma; Pieter E Postmus; Giuseppe Giaccone; Franz Schramel; Egbert F Smit
Accelerated cisplatin and high-dose epirubicin with G-CSF support in patients with relapsed non-small-cell lung cancer: feasibility and efficacy.
British journal of cancer 2001;85(10):1456-61.
2001: Cynthia Huisman; Pieter E Postmus; Giuseppe Giaccone; Egbert F Smit
A phase I study of sequential intravenous topotecan and etoposide in lung cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(11):1567-73.
2001: Tom G Sutedja; BJ Venmans; Egbert F Smit; Pieter E Postmus
Fluorescence bronchoscopy for early detection of lung cancer: a clinical perspective.
Lung cancer (Amsterdam, Netherlands) 2001;34(2):157-68.
2001: Martin Klein; Martin J B Taphoorn; Jan J Heimans; H M van der Ploeg; W Peter Vandertop; Egbert F Smit; Sieger Leenstra; C A Tulleken; Willem Boogerd; José S A Belderbos; W Cleijne; N K Aaronson
Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(20):4037-47.
2001: Cynthia Huisman; Giuseppe Giaccone; C J van Groeningen; GT Sutedja; Pieter E Postmus; Egbert F Smit
Combination of gemcitabine and cisplatin for advanced non-small cell lung cancer: a phase II study with emphasis on scheduling.
Lung cancer (Amsterdam, Netherlands) 2001;33(2-3):267-75.
2001: Carlos G Ferreira; Paul Van Der Valk; Simone W Span; Irene S Ludwig; Egbert F Smit; Frank A E Kruyt; HERBERT PINEDO; Harm van Tinteren; Giuseppe Giaccone
Expression of X-linked inhibitor of apoptosis as a novel prognostic marker in radically resected non-small cell lung cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(8):2468-74.
2001: BJ Venmans; TJ van Boxem; Egbert F Smit; Pieter E Postmus; Tom G Sutedja
Bronchial intraepithelial neoplastic lesions in head and neck cancer patients: results of autofluorescence bronchoscopy.
The Annals of otology, rhinology, and laryngology 2001;110(7 Pt 1):635-8.
2001: John W G van Putten; T Kerbush; Egbert F Smit; R van Rijswijk; J H Beijnen; Dirk T Sleijfer; Harry J M Groen
Dose-finding and pharmacological study of ifosfamide in combination with paclitaxel and carboplatin in resistant small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(6):787-92.
2001: Harm van Tinteren; Otto S Hoekstra; Egbert F Smit; Paul Verboom; Maarten Boers
Toward less futile surgery in non-small cell lung cancer? A randomized clinical trial to evaluate the cost-effectiveness of positron emission tomography.
Controlled clinical trials 2001;22(1):89-98.
2001: Giuseppe Giaccone; Egbert F Smit
Lung cancer.
Cancer chemotherapy and biological response modifiers 2001;19():485-534.
2000: Cynthia Huisman; Egbert F Smit; Giuseppe Giaccone; Pieter E Postmus
Second-line chemotherapy in relapsing or refractory non-small-cell lung cancer: a review.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(21):3722-30.
2000: Pieter E Postmus; H Haaxma-Reiche; Egbert F Smit; Harry J M Groen; H Karnicka; T Lewinski; Jan P van Meerbeeck; M Clerico; Anna Gregor; Desmond Curran; TM Sahmoud; A Kirkpatrick; Giuseppe Giaccone
Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy--a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(19):3400-8.
2000: AM Dingemans; J van Ark-Otte; Egbert F Smit; Pieter E Postmus; Giuseppe Giaccone
Validation of a polymerase chain reaction aided transcript titration assay (PATTY) for topoisomerase II in lung cancer samples.
Anticancer research 2000;20(5B):3549-54.
2000: Gerarda J Herder; Egbert F Smit; Paul J Borgstein; Pieter E Postmus
A patient with fatigue and subfebrile temperature.
The European respiratory journal 2000;16(1):184-6.
2000: nico van zandwijk; Egbert F Smit; Gijsbert W P M Kramer; Franz Schramel; Steven Gans; Joost M Festen; A Termeer; N J Schlosser; Channa Debruyne; Desmond Curran; Giuseppe Giaccone
Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(14):2658-64.
2000: Corneline Hoekstra; I Paglianiti; Otto S Hoekstra; Egbert F Smit; Pieter E Postmus; Gerrit J J Teule; Adriaan A Lammertsma
Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-D-glucose and positron emission tomography: an overview of different analytical methods.
European journal of nuclear medicine 2000;27(6):731-43.
2000: BJ Venmans; TJ van Boxem; Egbert F Smit; Pieter E Postmus; Tom G Sutedja
Outcome of bronchial carcinoma in situ.
Chest 2000;117(6):1572-6.
2000: Hendrik Verheul; Klaas Hoekman; Anita S Jorna; Egbert F Smit; HERBERT PINEDO
Targeting vascular endothelial growth factor blockade: ascites and pleural effusion formation.
The oncologist 2000;5 Suppl 1():45-50.
2000: Giuseppe Giaccone; Egbert F Smit; Jan P van Meerbeeck; Ted A W Splinter; Richard P Golding; HERBERT PINEDO; D Laan; Harm van Tinteren; Pieter E Postmus
A phase I-II study of gemcitabine and paclitaxel in advanced non-small-cell lung cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(1):109-12.
1999: Cynthia Huisman; Pieter E Postmus; Giuseppe Giaccone; Egbert F Smit
Second-line chemotherapy and its evaluation in small cell lung cancer.
Cancer treatment reviews 1999;25(4):199-206.
1999: Judith R Kroep; Giuseppe Giaccone; Daphne Voorn; Egbert F Smit; Jos H Beijnen; H Rosing; Catharina J A Van Moorsel; Cees J van Groeningen; Pieter E Postmus; HERBERT PINEDO; Godefridus J Peters
Gemcitabine and paclitaxel: pharmacokinetic and pharmacodynamic interactions in patients with non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(7):2190-7.
1999: Pieter E Postmus; Egbert F Smit
Chemotherapy for brain metastases of lung cancer: a review.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(7):753-9.
1999: Corneline Hoekstra; Otto S Hoekstra; J P Teengs; Pieter E Postmus; Egbert F Smit
Thoracic actinomycosis imaging with fluorine-18 fluorodeoxyglucose positron emission tomography.
Clinical nuclear medicine 1999;24(7):529-30.
1999: M Bakker; Winette T A van der Graaf; D Albertus Piers; EJ Franssen; Harry J M Groen; Egbert F Smit; W Kool; Harry Hollema; E A Müller; Elisabeth G E de Vries
99mTc-Sestamibi scanning with SDZ PSC 833 as a functional detection method for resistance modulation in patients with solid tumours.
Anticancer research 1999;19(3B):2349-53.
1999: BJ Venmans; Egbert F Smit; Pieter E Postmus; Tom G Sutedja
Re: Autofluorescence bronchoscopy in the detection of squamous metaplasia and dysplasia in current and former smokers.
Journal of the National Cancer Institute 1999;91(6):562-3.
1999: Gert Jan Meersma; M Bakker; Harry J M Groen; Ate G J van der Zee; P B Jensen; Giuseppe Giaccone; Elisabeth G E de Vries; Egbert F Smit
A PCR-aided transcript titration assay (PATTY) to measure topoisomerase I gene expression in human tumor specimens.
Anticancer research 1999;19(2A):1309-15.
1999: Harry J M Groen; Eelco Fokkema; Bonne Biesma; B Kwa; John W G van Putten; Pieter E Postmus; Egbert F Smit
Paclitaxel and carboplatin in the treatment of small-cell lung cancer patients resistant to cyclophosphamide, doxorubicin, and etoposide: a non-cross-resistant schedule.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):927-32.
1999: Sebo Withoff; Ate G J van der Zee; Steven de Jong; Harry Hollema; Egbert F Smit; Nanno H Mulder; Elisabeth G E de Vries
DNA topoisomerase IIalpha and -beta expression in human ovarian cancer.
British journal of cancer 1999;79(5-6):748-53.
1999: BJ Venmans; TJ van Boxem; Egbert F Smit; Pieter E Postmus; Tom G Sutedja
Results of two years expenience with fluorescence bronchoscopy in detection of preinvasive bronchial neoplasia.
Diagnostic and therapeutic endoscopy 1999;5(2):77-84.
1998: Jourik A Gietema; Harry J M Groen; S Meijer; Egbert F Smit
Effects of gemcitabine on renal function in patients with non-small cell lung cancer.
European journal of cancer (Oxford, England : 1990) 1998;34(1):199-202.
1998: Egbert F Smit; Eelco Fokkema; Bonne Biesma; Harry J M Groen; W Snoek; Pieter E Postmus
A phase II study of paclitaxel in heavily pretreated patients with small-cell lung cancer.
British journal of cancer 1998;77(2):347-51.
1997: M Bakker; J Renes; A Groenhuijzen; P Visser; Hetty Timmer-Bosscha; Michael Müller; H J Groen; Egbert F Smit; Elisabeth G E de Vries
Mechanisms for high methoxymorpholino doxorubicin cytotoxicity in doxorubicin-resistant tumor cell lines.
International journal of cancer. Journal international du cancer 1997;73(3):362-6.
1997: Wijnand Helfrich; R ten Poele; Gert Jan Meersma; Nanno H Mulder; Elisabeth G E de Vries; Lou de Leij; Egbert F Smit
A quantitative reverse transcriptase polymerase chain reaction-based assay to detect carcinoma cells in peripheral blood.
British journal of cancer 1997;76(1):29-35.
1996: Egbert F Smit; H J Groen; T A Splinter; Tjark Ebels; Pieter E Postmus
New prognostic factors in resectable non-small cell lung cancer.
Thorax 1996;51(6):638-46.
1995: J G Kosterink; M W de Jonge; Egbert F Smit; D Albertus Piers; R A Kengen; P E Postmus; D Shochat; Harry J M Groen; H T The; Lou de Leij
Pharmacokinetics and scintigraphy of indium-111-DTPA-MOC-31 in small-cell lung carcinoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(12):2356-62.
1995: M Bakker; Harry J M Groen; Egbert F Smit; J Smeets; M Riggi; Pieter E Postmus
Phase I study of high-dose epirubicin and vinorelbine in previously untreated non-small-cell lung cancer stage IIIB-IV.
British journal of cancer 1995;72(6):1547-50.
1995: Pieter E Postmus; Egbert F Smit; H Haaxma-Reiche; nico van zandwijk; Andrea Ardizzoni; Elisabeth Quoix; A Kirkpatrick; TM Sahmoud; G Giaccone
Teniposide for brain metastases of small-cell lung cancer: a phase II study. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(3):660-5.
1994: Sebo Withoff; Egbert F Smit; Gert Jan Meersma; Anke Van den Berg; Hetty Timmer-Bosscha; Klaas Kok; Pieter E Postmus; Nanno H Mulder; Elisabeth G E de Vries; Charles H C M Buys
Quantitation of DNA topoisomerase II alpha messenger ribonucleic acid levels in a small cell lung cancer cell line and two drug resistant sublines using a polymerase chain reaction-aided transcript titration assay.
Laboratory investigation; a journal of technical methods and pathology 1994;71(1):61-6.
1994: Egbert F Smit; H J Groen; Wim Timens; Wim J de Boer; Pieter E Postmus
Surgical resection for small cell carcinoma of the lung: a retrospective study.
Thorax 1994;49(1):20-2.
1993: Pieter E Postmus; Egbert F Smit; A Kirkpatrick; Ted A W Splinter
Testing the possible non-cross resistance of two equipotent combination chemotherapy regimens against small-cell lung cancer: a phase II study of the EORTC Lung Cancer Cooperative Group.
European journal of cancer (Oxford, England : 1990) 1993;29A(2):204-7.
1993: H J Groen; Egbert F Smit; H Haaxma-Reiche; Pieter E Postmus
Carboplatin as second line treatment for recurrent or progressive brain metastases from small cell lung cancer.
European journal of cancer (Oxford, England : 1990) 1993;29A(12):1696-9.
1992: Egbert F Smit; Elisabeth G E de Vries; Hetty Timmer-Bosscha; L F de Leij; J W Oosterhuis; Rik J Scheper; J J Weening; P E Postmus; Nanno H Mulder
In vitro response of human small-cell lung-cancer cell lines to chemotherapeutic drugs; no correlation with clinical data.
International journal of cancer. Journal international du cancer 1992;51(1):72-8.
1992: Egbert F Smit; T A Splinter; T C Kok
A phase I study of daily oral teniposide for 20 days.
Seminars in oncology 1992;19(2 Suppl 6):40-2.
1992: Pieter E Postmus; Egbert F Smit; H H Berendsen; Dirk T Sleijfer; H Haaxma-Reiche
Treatment of brain metastases of small cell lung cancer with teniposide.
Seminars in oncology 1992;19(2 Suppl 6):89-94.
1992: Egbert F Smit; B E Ousterhuis; H H Berendsen; Dirk T Sleijfer; Pieter E Postmus
Phase I study of oral teniposide (VM-26).
Seminars in oncology 1992;19(2 Suppl 6):35-9.
1992: Egbert F Smit; H H Berendsen; D Albertus Piers; J Smeets; A Riva; Pieter E Postmus
A phase II study of high dose epirubicin in unresectable non small cell lung cancer.
British journal of cancer 1992;65(3):405-8.
1992: Pieter E Postmus; Egbert F Smit; H H Berendsen; H Haaxma-Reiche
Second-line carboplatin-based chemotherapy for small cell lung cancer: the Groningen experience.
Seminars in oncology 1992;19(1 Suppl 2):17-23.
1991: Egbert F Smit; E G de Vries; C Meijer; N H Mulder; Pieter E Postmus
Limitations of the fast green assay for chemosensitivity testing in human lung cancer.
Chest 1991;100(5):1358-63.
1991: Egbert F Smit; P H B Willemse; Dirk T Sleijfer; D R A Uges; Pieter E Postmus; Sybren Meijer; P M Terheggen; Nanno H Mulder; Elisabeth G E de Vries
Continuous infusion carboplatin on a 21-day schedule: a phase I and pharmacokinetic study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(1):100-10.
1991: Pieter E Postmus; Egbert F Smit; H H Berendsen; D T Sleyfer
A feasibility study of testing new drugs for small-cell lung cancer in patients with a poor performance status.
Cancer chemotherapy and pharmacology 1991;27(6):490-1.
1990: A S Dofferhoff; H H Berendsen; J vd Naalt; H Haaxma-Reiche; Egbert F Smit; Pieter E Postmus
Decreased phenytoin level after carboplatin treatment.
The American journal of medicine 1990;89(2):247-8.
1990: Egbert F Smit; H H Berendsen; P E Postmus
Etoposide and mesothelioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(7):1281.
1990: D N Carney; L Grogan; Egbert F Smit; P Harford; H H Berendsen; Pieter E Postmus
Single-agent oral etoposide for elderly small cell lung cancer patients.
Seminars in oncology 1990;17(1 Suppl 2):49-53.
1989: Egbert F Smit; D N Carney; P Harford; D T Sleijfer; Pieter E Postmus
A phase II study of oral etoposide in elderly patients with small cell lung cancer.
Thorax 1989;44(8):631-3.
1989: Dirk T Sleijfer; Egbert F Smit; Sybren Meijer; Nanno H Mulder; Pieter E Postmus
Acute and cumulative effects of carboplatin on renal function.
British journal of cancer 1989;60(1):116-20.
1989: Elisabeth G E de Vries; Egbert F Smit; D E Vendrig; J J Holthuis; Nanno H Mulder
Phase I study of 21 days continuous infusion with vindesine.
British journal of cancer 1989;59(3):471-2.
1989: Egbert F Smit; H H Berendsen; Elisabeth G E de Vries; Nanno H Mulder; Pieter E Postmus
A phase II study of carboplatin and vincristine in previously treated patients with small-cell lung cancer.
Cancer chemotherapy and pharmacology 1989;25(3):202-4.